SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-022337
Filing Date
2023-06-26
Accepted
2023-06-26 06:20:13
Documents
15
Period of Report
2023-06-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 53237
2 ex10-1.htm EX-10.1 405942
3 ex10-2.htm EX-10.2 204852
4 ex99-1.htm EX-99.1 11612
  Complete submission text file 0001493152-23-022337.txt   939964

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ladx-20230621.xsd EX-101.SCH 3018
6 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ladx-20230621_lab.xml EX-101.LAB 34240
7 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ladx-20230621_pre.xml EX-101.PRE 22361
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3297
Mailing Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049
Business Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049 310-826-5648
LadRx Corp (Filer) CIK: 0000799698 (see all company filings)

IRS No.: 581642750 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15327 | Film No.: 231039375
SIC: 2836 Biological Products, (No Diagnostic Substances)